IBA is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in proton therapy and is leading innovation in the field with future technologies such as proton ARC Therapy* and proton FLASH* irradiation on its Proteus® platform. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from full-scale proton therapy centers as well as compact, single room solutions. Headquartered in Belgium and employing about 1,400 people worldwide, IBA has systems installed around the world. *Arc therapy is a work in progress and Flash therapy is currently under research. They are not available for sale.